Network pharmacology, molecular docking, and experimental validation to explore the potential mechanism of Long Mu Qing Xin mixture for the treatment of attention deficit hyperactivity disorder.

Li, Xuejun; Xiao, Zhen; Pu, Wenyan; Jiang, Zhiyan; Wang, Shumin; Zhang, Yixing

Li, Xuejun; Xiao, Zhen; Pu, Wenyan; Jiang, Zhiyan; Wang, Shumin; Zhang, Yixing.

Afiliação

Li X; Pediatrics, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xiao Z; Longhua Clinical Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pu W; Pediatrics, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jiang Z; Pediatrics, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang S; Longhua Clinical Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhang Y; Pediatrics, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Front Pharmacol ; 14: 1144907, 2023.

Article em En | MEDLINE | ID: mdl-37007045

Palavras-chave

Long Mu Qing Xin Mixture; attention deficit hyperactivity disorder; cAMP/PKA signaling pathway; dopamine; molecular docking; network pharmacology; spontaneously hypertensive rats

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article